Home
Medicines
Active Ingredients
Companies
DHPC
Advanced Search
Side Effect Reporting
Login
Medicines.ie | Reliable & Accurate Online Medicines Information | Home page
Home Medicines Active Ingredients Companies DHPC Advanced Search Side Effect Reporting
Login
  • Home
  • Companies
  • Otsuka Pharmaceutical UK Ltd.

Otsuka Pharmaceutical UK Ltd.

  • Address:

    Otsuka Pharmaceuticals (U.K.) Ltd., 2 Windsor Dials, Arthur Road, Windsor SL4 1RS, United Kingdom
  • Medical Information E-mail:

    medical.information@otsuka-europe.com
  • Telephone:

    44 (0)203 747 5300
  • Stock Availability:

    n/a

Company products

Medicine Status Monitoring SPC PIL XPIL Legal Category Active Ingredient(s) Company
ABILIFY 1 mg/ml oral solution
No Recent Update
SPC PIL Yes B
Aripiprazole
Otsuka Pharmaceutical UK Ltd.
ABILIFY 5 mg, 10 mg, 15 mg and 30 mg tablets
No Recent Update
SPC PIL Yes B
Aripiprazole
Otsuka Pharmaceutical UK Ltd.
ABILIFY 7.5 mg/ml solution for injection
No Recent Update
SPC PIL Yes B
Aripiprazole
Otsuka Pharmaceutical UK Ltd.
Abilify Orodispersible Tablets 10 mg, 15 mg and 30 mg
No Recent Update
SPC PIL Yes A
Aripiprazole
Otsuka Pharmaceutical UK Ltd.
Inaqovi 35 mg/100 mg film coated tablets
No Recent Update
SPC PIL Yes C
DecitabineCedazuridine
Otsuka Pharmaceutical UK Ltd.
Jinarc 15mg, 30mg, 15mg + 45mg, 30mg + 60mg, 30mg + 90mg tablets
Updated
SPC PIL Yes A
Tolvaptan
Otsuka Pharmaceutical UK Ltd.
Lupkynis 7.9 mg soft capsules
No Recent Update
SPC PIL Yes C
Voclosporin
Otsuka Pharmaceutical UK Ltd.
Samsca 7.5 mg, 15mg and 30mg Tablets
Updated
SPC PIL Yes B
Tolvaptan
Otsuka Pharmaceutical UK Ltd.

Brought to you by

Irish Pharmaceutical Healthcare Association | Home page

About

  • Help
  • About
  • Contact Us

Legal

  • Privacy Statement
  • Terms & Conditions
  • Accessibility

Search

  • Medicines
  • Active Ingredients
  • Companies

Award

Pharma Industry Awards 2020, Innovation of the Year, 2nd Place
Designed by eConcept Web Solutions
Direct Healthcare Professional Communications
This medicine and its document have not been updated in the last 30 days.
Product subject to medical prescription which may be renewed (B)
Product subject to medical prescription which may not be renewed (A)
Black Inverted Triangle: This medicinal product is subject to additional monitoring.
Product subject to restricted prescription (C)
Documents associated with this medicine were updated in the last 30 days.